Bicara Therapeutics Inc. Common Stock
BCAX | NASDAQ
$22.01
-$0.63 (-2.78%)
At close: Sep 21, 2026, 4:00 PM ET
$22.01
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 96.6M | 323.46M | 96.69M | 171.67M | 436.61M | 462.07M | 489.71M | 520.76M | 203.86M | 203.86M | 230.44M | n/a |
Short-Term Investments | 400.66M | 216.29M | 318.12M | 118.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 117.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 6.91M | 6.91M | 6.91M | 7.8M | 6.84M | 6.64M | 6.62M | 2.12M | 2.09M | 2.09M | 2.09M | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.56M | 5.16M | 7.25M | 7.21M | 7.79M | 8.69M | 12.82M | 756K | 2.22M | -230.44M | 100K | -4.16M |
Total Current Assets | 503.82M | 544.92M | 422.05M | 297.37M | 444.39M | 470.75M | 502.53M | 521.51M | 206.08M | 206.08M | 231.07M | n/a |
Property-Plant & Equipment | 1.51M | 1.77M | 2.03M | 2.1M | 2.35M | 688K | 845K | 544K | 619K | 619K | 815K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 8.42M | 8.68M | 8.94M | 127.32M | 9.2M | 7.32M | 66.66M | 2.66M | 2.71M | 2.71M | 2.91M | n/a |
Total Assets | 512.24M | 553.6M | 430.99M | 424.69M | 453.59M | 478.08M | 569.2M | 524.17M | 208.78M | 208.78M | 233.98M | n/a |
Account Payables | 8.46M | 7.44M | 7.79M | 3.66M | 2.91M | 2.74M | 4.51M | 1.96M | 4.68M | 4.68M | 3.19M | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.16M | n/a | n/a | n/a | n/a | n/a | 607K | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 33.85M | 1.91M | 5.04M | 3.99M | 2.17M | 1.68M | 9.79M | 1.81M | 1.12M | n/a | 1.74M | n/a |
Total Current Liabilities | 43.48M | 39.34M | 28.95M | 21.03M | 17.23M | 19.12M | 17.99M | 14.48M | 16.07M | 16.07M | 15.09M | n/a |
Long-Term Debt | n/a | 301K | n/a | 880K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 367.28M | n/a | 17K | 17.28M |
Total Long-Term Liabilities | n/a | 301K | 593K | 880K | 1.16M | n/a | 59.33M | 137K | 367.49M | 217K | 389K | 17.28M |
Total Liabilities | 43.48M | 39.64M | 29.54M | 21.91M | 18.39M | 19.12M | 77.32M | 14.62M | 383.56M | 16.28M | 15.47M | 17.28M |
Total Debt | 1.16M | 1.44M | 1.71M | 1.98M | 2.24M | 591K | 738K | 445K | 517K | 517K | 657K | n/a |
Book Value | 468.77M | 513.96M | 401.45M | 402.78M | 435.2M | 458.96M | 491.88M | 509.56M | -174.78M | 192.5M | 218.51M | -17.28M |
Book Value Per Share | 6.90 | 8.46 | 7.28 | 7.38 | 7.98 | 8.43 | 9.04 | 9.37 | -3.23 | 3.55 | 4.12 | -0.32 |
Common Stock | 8K | 8K | 7K | 7K | 7K | 7K | 7K | 7K | 2K | 2K | 2K | n/a |
Retained Earnings | -470.61M | -415.18M | -358.97M | -321.58M | -285.25M | -257.86M | -221.02M | -200.06M | -182.58M | -182.58M | -153.02M | n/a |
Comprehensive Income | -567K | -243K | 243K | -136K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -98.8M |
Shareholders Equity | 468.77M | 513.96M | 401.45M | 402.78M | 435.2M | 458.96M | 491.88M | 509.56M | -174.78M | 192.5M | 218.51M | -17.28M |
Total Investments | 400.66M | 216.29M | 318.12M | 235.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BCAX